Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,354.00
+5.40 (0.40%)
Jan 28, 2026, 3:00 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 219.14 billion as of January 28, 2026. Its market cap has decreased by -9.07% in one year.
Market Cap
219.14B
Enterprise Value
237.01B
Revenue
30.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,354.00
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 219.14B, an increase of 1,159.13%. That is a compound annual growth rate of 10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 219.14B | -6.75% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 539.96B |
| Ipca Laboratories | 369.11B |
| Ajanta Pharma | 337.15B |
| Emcure Pharmaceuticals | 281.44B |
| Gland Pharma | 276.12B |
| Piramal Pharma | 202.43B |
| Eris Lifesciences | 186.06B |
| Alembic Pharmaceuticals | 148.86B |